Work

Fireside chat: AI’s emerging role in oligonucleotide development and manufacturing

Year: 2026
Type: article
Abstract: Artificial intelligence (AI) is discussed with increasing frequency across the nucleic acid therapeutics field: it is already productive in early molecular design and in data-rich analytical tasks, and considerably less mature in the steps that connect synthesis to final product quality. In this Fireside Chat, Nucleic Acid Insights convened Srđan Maširević (Computational Biologist and Machine Learning Scientist, A*STAR’s Genome Institute of Singapore) and Bao Zhong Cai (VP, CMC, GondolaBio) to discuss where AI and machine learning (ML) earn a place in oligonucleotide production today, the data and process foundations they depend on, and how far the field is from digital twins, real-time impurity characterization, and autonomous synthesis. This discussion was a spin-off from the Nucleic Acid Insights Special Interest Group held in April 2026 on enhancing the efficiency and sustainability of oligonucleotide manufacturing.
Language: English
Subfield: Drug Discovery
Open Access status: hybrid
OpenAlex ID: W7225997786
FWCI:
Cites:
Cited by:
Related to: 10